Emma Nye has over two decades’ experience in histology, working primarily in a research setting.

In her first role as a researcher in a drug discovery start-up, Emma was responsible for setting up the histology department. In 2004 she joined the newly-created Experimental Histopathology unit at the London Research Institute, before it became part of the Crick. She played a major role in shaping and organising the lab, and in 2014 she became head of the lab to oversee the transition to the Crick.

Emma conducts and oversees many of the lab’s activities, specialising in mouse dissection, advanced immunohistochemistry and imaging techniques.

Qualifications and history

1998
University of the West of England, UK
BSc Biomedical Sciences
2000
Lorantis Ltd, Cambridge, UK
Research Scientist
2004
Cancer Research UK
Senior Scientific Officer
2009
Cancer Research UK
Operational Lab Head
2014
The Francis Crick Institute, London, UK
Head of Experimental Histopathology
Displaying 1 - 20 of 46
Last updated : 24 May 2022 02:46

USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer

Authors (19)
Nature Communications
Published
Crick labs/ facilities
Full details

Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study

Authors (89)
Nature Cancer
Published
Crick labs/ facilities
Full details

Immunogenomics of colorectal cancer response to checkpoint blockade: analysis of the KEYNOTE 177 trial and validation cohorts

Authors (29)
Gastroenterology
Published
Crick labs/ facilities
Full details

The transcription co-repressors MTG8 and MTG16 regulate exit of intestinal stem cells from their niche and differentiation into enterocyte vs secretory lineages

Authors (11)
Gastroenterology
Published
Crick labs/ facilities
Full details